The U.S. doesn’t have an official job code for clinical research professionals. David Vulcano explains why that gap is holding back the workforce.
- The Data Was Already There: RWE's Real Bottleneck Is People
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
- AI In Clinical Trials: Stop Hyping It, Start Proving It
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
ON-DEMAND WEBINARS
Learn how AI-enabled eCOA can reduce complexity in trial setup by cutting unnecessary meetings, speeding execution, and helping teams focus on what matters most.
Grant Williamson and Siba Noolu discuss best practices for ensuring quality and speed across EDC platforms for clinical operations, data management, and programming professionals.
Explore the forefront of wearable digital health technology and its potential impact on advancing clinical research and healthcare innovation.
Watch this presentation and demonstration of One Home for Sites for the latest updates on how the industry is coming together — even competitors — to alleviate the technology burden on research sites.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Clinical Trial Protocol]( "How A Small Biotech Partnered With Us To Navigate Trial Complexity With Confidence And Control")
How A Small Biotech Partnered With Us To Navigate Trial Complexity With Confidence And ControlEarly-phase trials often evolve rapidly. See how a flexible RTSM approach helped a biotech sponsor manage major protocol changes without disrupting study execution.
-
![GettyImages-1371324023 site payments]( "When Sites Don't Get Paid")
When Sites Don't Get PaidDiscover how Greenphire's innovative payment solutions can transform your clinical trial operations and ensure site sustainability.
-
![GettyImages-1257716223 fda guide]( "The Final DCT Guidance: I'm Not Mad At It")
The Final DCT Guidance: I'm Not Mad At ItExplore the FDA's 2024 final guidance on DCTs, including key updates that address previous concerns, affecting healthcare providers, sub-investigators, and sponsors.
-
![Ispor CEO]( "Hope In The Dark: Value In Alzheimer's Disease Research And Treatment")
Hope In The Dark: Value In Alzheimer's Disease Research And TreatmentThe May/June 2025 issue of Value & Outcomes Spotlight explores the health economics and outcomes research (HEOR) and its contribution to research and treatment of Alzheimer’s disease.
-
![GettyImages-1433100886 budgeting]( "Clinical Trial Budgeting Faces Pressure To Modernize")
Clinical Trial Budgeting Faces Pressure To ModernizeOutdated budget data slows trial startup. Real-time market benchmarking helps sites and sponsors negotiate faster and get treatments to patients sooner.
-
![GettyImages-927809262 EDC medrio]( "A Guide To Electronic Data Capture (EDC)")
A Guide To Electronic Data Capture (EDC)EDC systems are designed to support a wide range of clinical research while ensuring compliance with global regulatory standards, revolutionizing data management in clinical trials.
-
![cro-vendor-selection-GettyImages-1220794892]( "No-Frills, High-Impact Vendor Oversight: 4 Principles That Never Let Me Down")
No-Frills, High-Impact Vendor Oversight: 4 Principles That Never Let Me DownDiscover a streamlined four-pillar framework for vendor oversight. Learn how tracking essential KPIs across time, budget, quality, and relationships drives accountability in clinical operations.
-
![AI, digital innovation-GettyImages-2202490582]( "Building A Clinical Research AI Governance Framework")
Building A Clinical Research AI Governance FrameworkLearn how structured oversight, transparency, and collaboration help ensure compliance, reduce bias, and build trust while enabling innovation in increasingly data-driven trials.
-
![electronic-medical-technology-GettyImages-1204743045]( "Broadening Eligibility Criteria Among Cancer Clinical Trials Patients")
Broadening Eligibility Criteria Among Cancer Clinical Trials PatientsThis study challenges the commonly applied exclusionary approach to clinical trials, particularly cancer trials, that underrepresent certain populations and limit the generalizability of research advancements.
-
![gettyimages-1154110666 decentralized trials]( "You Don't Have To Digitize Everything, You Just Have To Start")
You Don't Have To Digitize Everything, You Just Have To StartFeeling left behind by the sudden digitization of clinical trials? Decentralized clinical trials can be adapted to best serve the patient population, condition, or therapy you’re investigating.
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
- The Data Was Already There: RWE's Real Bottleneck Is People
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
RECENT NEWSLETTERS
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
